The rapid evolution of artificial intelligence and other forms of machine learning (AI/ML) in health care has exposed the need for federal coverage and payment policies that promote innovation and protect patient interests. While the Food and Drug Administration (FDA) has moved forward to regulate software as a medical device (SaMD), and the American Medical […]
